🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The Multiple Myeloma Hub was pleased to speak with Rahul Banerjee, MD, FACP, Fred Hutch Cancer Center, Seattle, US. We asked about the current treatment recommendations and unmet needs in early relapsed/refractory #MultipleMyeloma. Watch here: loom.ly/0VMKVJ0 #mmsm #myeloma #MedEd

And James Davis, PharmD, BCOP and I were the first in line - come join us for a great #MMsm talk about optimizing myeloma therapies as pharmacists and physicians! Cc HOPARX

Sagar Lonial MD can we have this at IMS?!

#relapsed #myeloma With Sara Scott, PharmD, BCOP Danai Dima #HOPA2025! Hope we can deliver a presentation almost as good as James Davis, PharmD, BCOP and Rahul Banerjee, MD, FACP !

Great program- thank you to our moderator Sara Scott, PharmD, BCOP , #PTCE and #HOPA James Davis, PharmD, BCOP

Thank you PTCE and HOPARX for the opportunity to present with this fab crew!

Fred Hutch is well represented at #ONSCongress! Our #oncologynurses are in Denver presenting their latest findings in cancer care delivery at the 50th Annual Congress of Oncology Nursing Society. Check out our upcoming podium and poster sessions here: bit.ly/4jvYfqx

Colorado CBCI; Alabama UAB O'Neal Comprehensive Cancer Center; NY Columbia University Raj Chakraborty; Tennesse @ Vanderbilt Bhagirath Dholaria, MD ; Wisconsin Medical College of Wisconsin Binod Dhakal and Madison Natalie Callander; Washington Fred Hutch Cancer Center Rahul Banerjee, MD, FACP Danai Dima ; Oregon OHSU Knight Cancer Institute R. Silberman and E. Medvedova.

We need more healthcare organizations to do what these major organizations have done. End MOC. End physician burnout. Initial certification, licensure, and CME is sufficient. Join and support National Board of Physicians and Surgeons

International myeloma working group immunotherapy committee recommendation on sequencing CART, bispecific antibodies immunotherapy for treatment of multiple myeloma. IMWG. ⁦Luciano J Costa⁩ ⁦Rahul Banerjee, MD, FACP⁩ ⁦International Myeloma Foundation⁩ nature.com/articles/s4137…

‼️Join us TODAY at 6pm CET Register for FREE Rahul Banerjee, MD, FACP Mohamad Mohty Sanofi

Thank you again to Mateo Mejia Weill Cornell Medicine for this very kind invitation! I love getting to use all my hashtags in a single presentation: #downwithdex, #topeeornottopee and more while talking about myeloma. More work to be done here for sure!

So excited to share that my piece on Unmet Palliative Care Needs in Patients with Multiple Myeloma was featured in Hematopoiesis ASH. Huge thank you to Agrima Mian and Hetty Carraway for their help and support as well as all of my incredible mentors! #MMSM #PallOnc

Thank you OncLive.com for highlighting our data from CARTITUDE -4 #ASCO25

It's the last day of ASCO #ASCO25 and the last day of #OntheClock ⏱️ with MedNews Week. In this clip, MinhTri Nguyen, MD, of Stanford Health Care, discusses the SERENA6 data with Yan Leyfman, MD Did he beat the clock? 👀

Fantastic day 1 in Binaytara Best of ASCO in Seattle with great speakers, discussions, Q&A: Interactive & fun, also with Greek mythology :-) Fred Hutch Cancer Center Nicole D. Fleming MD Binay Shah, MD, MHA Chirag Shah Vyshak Venur, MD Lisa Tachiki, MD Danai Dima Ronan Hsieh, MD, MS Mazyar Shadman, MD MPH Hsieh Lab Lei Deng, MD (He/Him)

Phenomenal 2nd day Binaytara Best of ASCO with interactions with colleagues/friends in broader community! Stellar speakers & team based learning! Binay Shah, MD, MHA Nicole D. Fleming MD Fred Hutch Cancer Center Mazyar Shadman, MD MPH Lei Deng, MD (He/Him) Diane Tseng Hiba Khan MD MPH Lisa Tachiki, MD Easter Ho Ronan Hsieh, MD, MS Hsieh Lab

1/ Excellent news for 🇺🇸 patients receiving CAR-T therapy! FDA has listened to data and relaxed CRS monitoring and driving restrictions for liso-cel for #lymsm / ide-cel for #MMsm. Huge step to lower time toxicity and disparities. Can this be fixed for all CAR-T products?

2/ Another great publication by US Myeloma Immunotherapy Consortium, this one led by Beatrice Razzo Al Garfall 👏 Adding Surbhi Sidana, MD Krina Patel #dorishansen Danai Dima Andrew Portuguese Gurbakhash Kaur Larry Anderson,MD,PhD,FACP Yi Lin Chris Ferreri Plasma Cell Pete Leyla Shune MD and many more!

Shocker for me. ODAC votes against belantamab risk benefit for myeloma. I hope that this vote reflects the way the questions were narrowly worded. I still hope the drug still gets FDA approved.